MACEROLA, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 802
EU - Europa 476
AS - Asia 90
AF - Africa 64
OC - Oceania 1
SA - Sud America 1
Totale 1.434
Nazione #
US - Stati Uniti d'America 792
IT - Italia 131
SE - Svezia 124
DE - Germania 80
AT - Austria 66
CN - Cina 40
CI - Costa d'Avorio 36
SG - Singapore 28
BG - Bulgaria 26
GB - Regno Unito 25
SN - Senegal 18
CA - Canada 10
NG - Nigeria 10
VN - Vietnam 10
HK - Hong Kong 9
FI - Finlandia 8
RU - Federazione Russa 3
BE - Belgio 2
DK - Danimarca 2
EE - Estonia 2
RO - Romania 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
FR - Francia 1
MD - Moldavia 1
NP - Nepal 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.434
Città #
Chandler 171
Woodbridge 67
Fairfield 63
Ashburn 58
Houston 54
Vienna 46
New York 40
Seattle 37
Abidjan 36
Florence 30
Cambridge 27
Pisa 26
Sofia 26
Ann Arbor 23
Milan 23
Beijing 21
Frankfurt am Main 21
Wilmington 21
Princeton 20
Bremen 18
Dakar 18
Lawrence 18
Medford 14
Redmond 12
Des Moines 11
London 11
Lagos 10
Ottawa 10
Vicopisano 10
Hong Kong 9
Lancaster 6
Bologna 5
Dong Ket 5
Nanjing 5
Hebei 3
Helsinki 3
Lugo 3
Nürnberg 3
Washington 3
Brussels 2
Cluj-napoca 2
Dearborn 2
Guangzhou 2
Hangzhou 2
Jiaxing 2
Lyngby 2
Rome 2
San Francisco 2
Serra 2
Shanghai 2
Stockholm 2
Tallinn 2
Borgomanero 1
Boydton 1
Brisbane 1
Brno 1
Capannori 1
Cedar Knolls 1
Chisinau 1
Chiswick 1
Como 1
Düsseldorf 1
Grado 1
Izmir 1
Jinan 1
Kathmandu 1
Kunming 1
Lappeenranta 1
Lerici 1
Miami 1
Norwalk 1
Piacenza 1
Prescot 1
Riyadh 1
San Diego 1
Seacroft 1
Shenyang 1
São Paulo 1
Totale 1.039
Nome #
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 126
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 123
Pre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: a positive prognostic factor for survival? 99
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 91
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 89
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 79
null 78
Clinical Impact of Pretreatment EGFR T790M Mutation in Lung Adenocarcinoma Patients 78
null 77
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 77
null 66
COVID-19 autopsy cases: detection of virus in endocrine tissues 64
Tailored surgery according to molecular analysis in differentiated thyroid carcinomas 58
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 50
Fine-needle aspiration cytology and histological types of thyroid cancer in the elderly: Evaluation of 9070 patients from a single referral centre 45
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 45
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness 40
Molecular genetics of follicular-derived thyroid cancer 33
Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules 29
AUTOPSY STUDY OF TESTICLES IN COVID-19: UPREGULATION OF IMMUNE-RELATED GENES AND DOWNREGULATION OF TESTIS-SPECIFIC GENES 28
Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma 22
Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms 21
Suppression of Pituitary Hormone Genes in Subjects Who Died From COVID-19 Independently of Virus Detection in the Gland 19
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-YearMono-Institutional Experience 19
Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management 18
Predictive Biomarkers in Thyroid Cancer 14
The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma 3
Totale 1.491
Categoria #
all - tutte 4.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201960 0 0 0 0 0 0 0 2 2 15 23 18
2019/2020169 20 11 6 8 18 17 17 12 18 19 16 7
2020/202164 5 4 4 1 4 1 3 4 5 13 9 11
2021/2022180 2 2 3 2 25 23 16 17 9 8 19 54
2022/2023590 56 79 30 55 69 60 6 51 117 6 50 11
2023/2024240 29 27 40 44 34 50 11 5 0 0 0 0
Totale 1.491